Literature DB >> 9195903

Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription.

P F Lebowitz1, W Du, G C Prendergast.   

Abstract

Rho regulates cytoskeletal actin structure and integrin-mediated cell adhesion. Rho also has a role in cell growth regulation and is required for cell transformation by oncogenic Ras. Recently, it has been demonstrated that Rho can activate transcription from the c-fos serum response element (SRE). This raised the possibility that functions required for Rho-mediated cell transformation might overlap with those involved in transcriptional regulation. Here we show that RhoB can activate the SRE and can synergize in cell transformation with constitutively activated Raf-CAAX. Significantly, unprenylated forms of RhoB that are biologically inert and unable to transform cells can still activate SRE-dependent transcription. This finding suggests that transcriptional activation by Rho may be separable from its cell transforming functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195903     DOI: 10.1074/jbc.272.26.16093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Authors:  Patricia A Solski; Whitney Helms; Patricia J Keely; Lishan Su; Channing J Der
Journal:  Cell Growth Differ       Date:  2002-08

2.  Geranylgeranyltransferase I of Candida albicans: null mutants or enzyme inhibitors produce unexpected phenotypes.

Authors:  R Kelly; D Card; E Register; P Mazur; T Kelly; K I Tanaka; J Onishi; J M Williamson; H Fan; T Satoh; M Kurtz
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

3.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

4.  CDC42 and FGD1 cause distinct signaling and transforming activities.

Authors:  I P Whitehead; K Abe; J L Gorski; C J Der
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

5.  RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.

Authors:  E Sahai; A S Alberts; R Treisman
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

6.  Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.

Authors:  W Du; P F Lebowitz; G C Prendergast
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.

Authors:  Ian Cushman; Patrick J Casey
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

8.  Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.

Authors:  Daphne A Haas-Kogan; Anuradha Banerjee; Mehmet Kocak; Michael D Prados; J Russell Geyer; Maryam Fouladi; Tracy McKnight; Tina Young Poussaint; Alberto Broniscer; Susan M Blaney; James M Boyett; Larry E Kun
Journal:  Neuro Oncol       Date:  2008-04-16       Impact factor: 12.300

Review 9.  Biochemical and docking analysis of substrate interactions with polyisoprenylated methylated protein methyl esterase.

Authors:  R Duverna; S Y Ablordeppey; N S Lamango
Journal:  Curr Cancer Drug Targets       Date:  2010-09       Impact factor: 3.428

10.  Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.

Authors:  A S Alberts; R Treisman
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.